EDGAR Filing Documents for 0001654954-18-012900

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-18-012900

Filing Date

2018-11-16

Accepted

2018-11-16 16:59:57

Documents

Period of Report

2018-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	sbfm_form10-q.htm	10-Q	541352
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex31-1.htm	EX-31.1	12410
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex31-2.htm	EX-31.2	12276
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	8201
5	IMAGE	sbfm_form10-q000.jpg	GRAPHIC	5705
6	IMAGE	sbfm_form10-q001.jpg	GRAPHIC	12202
7	IMAGE	sbfm_form10-q002.jpg	GRAPHIC	15200
8	IMAGE	sbfm_form10-q003.jpg	GRAPHIC	8595
	Complete submission text file	0001654954-18-012900.txt		1501976

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	sbfm-20180930.xml	EX-101.INS	84996
10	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20180930.xsd	EX-101.SCH	17194
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20180930_cal.xml	EX-101.CAL	37985
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20180930_def.xml	EX-101.DEF	18110
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20180930_lab.xml	EX-101.LAB	119222
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20180930_pre.xml	EX-101.PRE	86130

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)